✦ LIBER ✦

Opioid peptides: potential for drug development

✍ Scribed by Jane V. Aldrich; Jay P. McLaughlin

Book ID: 119226488
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 256 KB
Volume: 9
Category: Article
ISSN: 1740-6749
DOI: 10.1016/j.ddtec.2011.07.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Peptide Kappa Opioid Receptor Ligands: P

Peptide Kappa Opioid Receptor Ligands: Potential for Drug Development

✍ Jane V. Aldrich; Jay P. McLaughlin 📂 Article 📅 2009 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 232 KB

Endomorphins: potential roles and therap

Endomorphins: potential roles and therapeutic indications in the development of opioid peptide analgesic drugs

✍ Wei X. Liu; Rui Wang 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 856 KB

The application of endomorphins as clinical available analgesic drugs has been impeded by their relatively poor receptor selectivity compared with alkaloid analgesics, rapid degradation in vivo, inefficient to penetrate the blood-brain barrier (BBB), and undesirable or toxic effects, such as acute t

Bi- or multifunctional opioid peptide dr

Bi- or multifunctional opioid peptide drugs

✍ Peter W. Schiller 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 193 KB

Opioid peptides and long-term potentiati

Opioid peptides and long-term potentiation

✍ ANIKSZTEJN, L; BENARI, Y 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 278 KB

Biologically Active Peptides: Prospects

Biologically Active Peptides: Prospects for Drug Development

✍ Hughes, J. 📂 Article 📅 1980 🏛 The Royal Society 🌐 English ⚖ 911 KB

Neuroprotective peptide drug delivery an

Neuroprotective peptide drug delivery and development: potential new therapeutics

✍ Illana Gozes 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 80 KB